Scherrer, Alexandra U; von Wyl, Viktor; Fux, Christof A; Opravil, Milos; Bucher, Heiner C; Fayet, Aurélie; Decosterd, Laurent A; Hirschel, Bernhard; Khanlari, Bettina; Yerly, Sabine; Klimkait, Thomas; Furrer, Hansjakob; Ledergerber, Bruno; Günthard, Huldrych F; Swiss HIV Cohort Study, (2010). Implementation of raltegravir in routine clinical practice: selection criteria for choosing this drug, virologic response rates, and characteristics of failures. Journal of acquired immune deficiency syndromes JAIDS, 53(4), pp. 464-71. Philadelphia, Pa.: Lippincott Williams & Wilkins 10.1097/QAI.0b013e3181bca4ec
Full text not available from this repository. (Request a copy)Raltegravir (RAL) achieved remarkable virologic suppression rates in randomized-clinical trials, but today efficacy data and factors for treatment failures in a routine clinical care setting are limited.
Item Type: |
Journal Article (Original Article) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Infectiology |
UniBE Contributor: |
Fux, Christoph Andreas, Furrer, Hansjakob |
ISSN: |
0894-9255 |
Publisher: |
Lippincott Williams & Wilkins |
Language: |
English |
Submitter: |
Factscience Import |
Date Deposited: |
04 Oct 2013 14:12 |
Last Modified: |
05 Dec 2022 14:02 |
Publisher DOI: |
10.1097/QAI.0b013e3181bca4ec |
PubMed ID: |
19841590 |
Web of Science ID: |
000275486600005 |
URI: |
https://boris.unibe.ch/id/eprint/2710 (FactScience: 205578) |
Actions (login required)
 |
Edit item |